Phillips-Medisize A/S — Credit Rating and Financial Key Figures

Phillips-Medisize A/S (CVR number: 24053415K) is a company from STRUER. The company reported a net sales of 425.6 mDKK in 2024, demonstrating a decline of -11.7 % compared to the previous year. The operating profit percentage was at 4.3 % (EBIT: 18.1 mDKK), while net earnings were 12.1 mDKK. The profitability of the company measured by Return on Assets (ROA) was 8.4 %, which can be considered good but Return on Equity (ROE) was 6.8 %, which can be considered decent. The equity ratio, a key indicator for solidity, stood at 51.4 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Phillips-Medisize A/S's liquidity measured by quick ratio was 1.4 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.